Stablecoin Standard Establishes StableCheck: An Independent Stablecoin Evaluation Framework https://mma.prnewswire.com/media/2806407/Stablecoin_Standard.jpg StableCheck evaluates fiat-backed payment stablecoins across six key factors: reserve quality, redemption reliability, transparency, governance, market performance, and risk controls. Stablecoin Standard (“SCS”), the global industry body for stablecoins, today formally announced the launch of the StableCheck methodology, following their Stablecoin conference with State Street […]

The company empowers architects and builders to go from plan to permit in days, not months-accelerating the construction of more affordable homes across the U.S. Spacial, creator of an AI-powered platform automating residential engineering and permitting, announced a $10 million seed round led by TLV Partners, with participation from Mango Capital, Re Angels, and HTV.

Expanding Global Access to Diagnostics for Drug-Resistant Tuberculosis Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a new milestone in the global fight against tuberculosis (TB). This designation affirms the test's compliance with the WHO's rigorous standards for quality, safety, and performance, and

Sojern, the leading AI-powered marketing platform built for hospitality, is thrilled to announce the formation of its first 2025 European Destinations Advisory Board. Similar to Sojern's North America-based Destinations Advisory Board, this board is composed of influential destination leaders from across Europe who are committed to delivering new and innovative solutions to the challenges destination

— Establishes the first public securities-focusedtokenization infrastructure company — Industry-leading end-to-endtokenization platform with blue-chip institutional partnerships including BlackRock, Apollo, Hamilton Lane and VanEck — Upsized $225 million in committed common stock PIPE financing led by new and existing blue-chip institutional investors, including Arche, Borderless Capital, Hanwha Investment & Securities, InterVest, and ParaFi Capital — Transaction

— DRUO is a global direct-debit payment network enabling businesses to accept payments directly from bank accounts. — The company connects 10,000 financial institutions and services almost 1 million users in the United States and Latin America. — The seed round led by Global PayTech Ventures positions DRUO to expand to over 30 countries in

(NasdaqGM:SWKS),(NASDAQ:QRVO), Key Highlights Enhances scale with revenue of $7.7 billion and Adjusted EBITDA of $2.1 billion1 Combines complementary product and technology portfolios and world-class engineering capabilities, creating R&D scale to deliver innovative RF solutions Creates $5.1 billion mobile business positioned to address rising RF complexity Establishes $2.6 billion diversified Broad Markets platform with a growing

(NasdaqGM:IVVD), NEW HAVEN, Conn., Oct. 28, 2025 (GLOBE NEWSWIRE) — WHAT: Invivyd, Inc. (Nasdaq: IVVD) is hosting the previously announced live webcast to present an overview of the company's REVOLUTION clinical program, Invivyd's development program for VYD2311, a vaccine-alternative monoclonal antibody candidate for the prevention of COVID. The session will feature key members of the

New software release includes enhanced automation, governance, real-time analytics, and self-service data preparation Altair, a global leader in computational intelligence, today announced major updates across Altair® RapidMiner®, its data analytics and AI platform, to help organizations operationalize intelligence, bridging human insight, data automation, and agentic AI collaboration across a unified ecosystem. https://mma.prnewswire.com/media/2804975/Altair_Newsroom_NR_Altair_RapidMiner_2025_Social.jpg The latest updates

Reqorsa® Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer Combining REQORSA with Alectinib Further Increased Apoptosis and Improved Treatment Outcomes in a Mouse Model Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today